|
TLSI Trisalus Life Sciences Inc 1826667 |
| Balance Sheet |
|
Current Assets
|
23,808,000 |
|
Assets
|
27,477,000 |
|
Current Liabilities
|
9,918,000 |
|
Liabilities
|
47,911,000 |
|
Equity
|
-20,434,000 |
|
Shares Out
|
29,311,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-35,136,000 |
|
Investing Cash Flow
|
-295,000 |
| Market Analysis |
Market Cap
|
138,936,503 |
|
Price
|
4.93 |
|
BVPS
|
3.29 |
|
PB
|
1.50 |
|
EPS
|
-1.70 |
|
PS
|
4.73 |
|
FCF
|
-35,431,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/01 |
-1.56 |
5/15 |
-0.60 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TLSI documents filed with the SEC.
TLSI Filings
Clear
